Tamoxifen-associated polypoid endometriosis mimicking an ovarian neoplasm
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최인호 | - |
dc.contributor.author | 진소영 | - |
dc.contributor.author | 진윤미 | - |
dc.contributor.author | 이정재 | - |
dc.contributor.author | 김동원 | - |
dc.date.accessioned | 2021-08-11T21:25:18Z | - |
dc.date.available | 2021-08-11T21:25:18Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2287-8572 | - |
dc.identifier.issn | 2287-8580 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11294 | - |
dc.description.abstract | Tamoxifen has been widely used for adjuvant treatment of breast cancer, but several gynecological side effects have been noted, including endometrial hyperplasia, polyp and carcinoma. Polypoid endometriosis is one of the extremely rare benign complications associated with tamoxifen therapy. A 66-year-old postmenopausal woman, who had received left partial mastectomy due to breast cancer (about 4 years ago) and was taking tamoxifen treatment, had an ovarian cyst on ultrasonography. Pelvic magnetic resonance imaging suggested tamoxifen-associated endometrial and ovarian changes, especially a 4.1×3.4-cm-sized, well-defined, multicystic mass in the right ovary. She received hysterectomy with bilateral salpingo-oophorectomy. Microscopically, the right paratubal mass showed endometrial glands and stroma, and immunohistochemical staining for CD10 confirmed the endometrial nature of the stroma. Three cases of polypoid endometriosis have been reported in the Korean literature, but in none of the cases, polypoid endometriosis was associated with tamoxifen use. Herein, we report the first case of polypoid endometriosis associated with tamoxifen treatment in Korea. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한산부인과학회 | - |
dc.title | Tamoxifen-associated polypoid endometriosis mimicking an ovarian neoplasm | - |
dc.title.alternative | Tamoxifen-associated polypoid endometriosis mimicking an ovarian neoplasm | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5468/ogs.2015.58.4.327 | - |
dc.identifier.bibliographicCitation | Obstetrics & Gynecology Science, v.58, no.4, pp 327 - 330 | - |
dc.citation.title | Obstetrics & Gynecology Science | - |
dc.citation.volume | 58 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 327 | - |
dc.citation.endPage | 330 | - |
dc.identifier.kciid | ART002013096 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Endometriosis | - |
dc.subject.keywordAuthor | Polyps | - |
dc.subject.keywordAuthor | Tamoxifen | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.